Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: OPHIREX, INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-04-05 to 2024-07-20
Current total value of award: $13827499
Description: FOLLOW ON PHASE III RESEARCH AND DEVELOPMENT SBIR FOR PROJECT TITLED, BROAD-SPECTRUM SNAKEBITE ANTIDOTE: ORAL PRODUCT DEVELOPMENT AND IV CLINICAL STUDY